Skip to main content
Caplight Logo









Nanovision Biosciences

Nanovision Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://nanovisionbio.com/

Company Overview

Nanovision Biosciences is a biotechnology company developing a nanotechnology-based retinal prosthesis designed to restore sight to patients with degenerative retinal disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Sensors, Defense Tech

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

retinal prosthesisbionic eyeneural stimulationnanowire technologyoptoelectronic sensorsimplantable medical devicelow-light imagingneuroprostheticsage-related macular degenerationAMDretinitis pigmentosaRPbiotech hardwaredefense imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanovision Biosciences Comparables

Compare Nanovision Biosciences with similar companies based on industry and business-model similarity.

Nanovision Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Science Corporation
86%
iBionics Inc.
85%
Bionic Vision Technologies
83%

Nanovision Biosciences Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 15, 2024

    Grew 114% QoQ, from 97 to 208 employees.

  • Jun 19, 2024

    Grew 18% QoQ, from 82 to 97 employees.

Nanovision Biosciences Filings

Explore SEC and related filing metadata, where available.

Nanovision Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nanovision Biosciences's valuation, stock price, and market status.

Is Nanovision Biosciences a public or private company?

Nanovision Biosciences is a private company.

What is the current stock price of Nanovision Biosciences?

Nanovision Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Nanovision Biosciences worth (valuation)?

Valuation information for Nanovision Biosciences is not publicly available.

Can I buy Nanovision Biosciences stock?

Nanovision Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nanovision Biosciences's last funding round?

Funding round information for Nanovision Biosciences is not publicly available.

Who are the main investors in Nanovision Biosciences?

Investor information for Nanovision Biosciences is not publicly disclosed.

Will Nanovision Biosciences IPO soon?

No public IPO plans have been announced for Nanovision Biosciences.

How can I track Nanovision Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanovision Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range294
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?